Insights for Navigating an Uncertain World
“US Federal Regulations Require Safety Testing of Proteins in New Vaccines. They Didn’t Even do That with The First One, and Now We Have Vaccine Failure Less Than a Year Later. Moderna has just announced that they will have a vaccine “ready” for the Omicron variant early next year. So what does that mean? Will they be able to start shipping it for distribution and use? Or will they be required by FDA to conduct studies – back to square one?”
Mark Skidmore is Professor of Economics at Michigan State University where he holds the Morris Chair in State and Local Government Finance and Policy. His research focuses on topics in public finance, regional economics, and the economics of natural disasters. Mark created the Lighthouse Economics website and blog to share economic research and information relevant for navigating tumultuous times. View more posts